Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.

Weiquan Liang,Yiyu Lu,Xingxi Pan, Yunxiang Zeng,Weiqiang Zheng,Yiran Li, Yuanhang Nie,Dongbing Li,Dongliang Wang

Pharmacogenomics and personalized medicine（2022）

引用 3|浏览5

暂无评分

摘要

There was a significant association between low FAM181A-AS1 expression in LUAD patients and poor survival and immune infiltration. The FAM181A-AS1 gene may provide a useful biomarker for LUAD prognosis and immunotherapy response.

查看译文

关键词

FAM181A-AS1,biomarker,immune infiltration,lung adenocarcinoma,prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要